Imidazo[1,2-a]pyridine derivatives for the treatment of gastrointestinal diseases
申请人:AstraZeneca AB
公开号:EP1105390B1
公开(公告)日:2003-06-04
NEW COMPOUNDS
申请人:AstraZeneca AB
公开号:EP1105390A2
公开(公告)日:2001-06-13
US6613775B1
申请人:——
公开号:US6613775B1
公开(公告)日:2003-09-02
[EN] NEW COMPOUNDS<br/>[FR] NOUVEAUX COMPOSES
申请人:ASTRA AB
公开号:WO2000010999A2
公开(公告)日:2000-03-02
The present invention relates to novel compounds, and therapeutically acceptable salts thereof of formula (I), which inhibit exogenously or endogenously stimulated gastric acid secretion and thus can be used in the prevention and treatment of gastrointestinal inflammatory diseases.
Imidazo[1,2-a]pyridine compounds
申请人:AstraZeneca AB
公开号:US06613775B1
公开(公告)日:2003-09-02
The present invention relates to novel compounds, and therapeutically acceptable salts thereof of the formula (I), which inhibit exogenously or endogenously stimulated gastric acid secretion and thus can be used in the prevention and treatment of gastrointestinal inflammatory diseases.